Safety and Feasibility of Riociguat Therapy for the Treatment of Chronic Pulmonary Arterial Hypertension in Infancy

被引：8
|
作者：
Giesinger, Regan E. [1 ]
Stanford, Amy H. [1 ]
Thomas, Brady [1 ]
Abman, Steven H. [2 ]
McNamara, Patrick J. [1 ]
机构：
[1] Univ Iowa, Dept Pediat, Iowa City, IA USA
[2] Univ Colorado, Dept Pediat, Denver, CO USA
来源：
JOURNAL OF PEDIATRICS | 2023年 / 255卷
关键词：
SOLUBLE GUANYLATE-CYCLASE; BRONCHOPULMONARY DYSPLASIA; ECHOCARDIOGRAPHY; SILDENAFIL; DISEASE;
D O I：
10.1016/j.jpeds.2022.11.026
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
The effects of riociguat, an oral-soluble guanylate-cyclase stimulator, were studied in 10 infants with chronic pulmonary arterial hypertension. Respiratory status (n = 8/10), right heart dilation (n = 7/10), function (n = 9/10), and chronic pulmonary arterial hypertension (n = 8/10) improved. Median decrement in systolic (12 [4, 14]), diastolic (14 [7, 20]), and mean arterial (14 [10, 17]) pressures were noted; no critical hypotension or hypoxemia occurred.
引用
收藏
页码：224 / +
页数：7
相关论文
共 50 条
  • [31] Riociguat for the treatment of pulmonary hypertension
    Schermuly, Ralph T.
    Janssen, Wiebke
    Weissmann, Norbert
    Stasch, Johannes-Peter
    Grimminger, Friedrich
    Ghofrani, Hossein Ardeschir
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (04) : 567 - 576
  • [32] Riociguat for the treatment of pulmonary hypertension
    Hambly, Nathan
    Granton, John
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (06) : 679 - 695
  • [33] Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry
    Halank, Michael
    Humbert, Marc
    Gomez Sanchez, Miguel-Angel
    Pittrow, David
    Hoeper, Marius
    Gruenig, Ekkehard
    Ghofrani, H. Ardeschir
    Wirtz, Hubert
    Klose, Hans
    Ewert, Ralf
    Lange, Tobias J.
    Klotsche, Jens
    Meier, Christian
    Brunn, Monika
    Simonneau, Gerald
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [34] Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
    Burudpakdee, Chakkarin
    Shah, Anshul
    Joish, Vijay N.
    Divers, Christine
    Yaldo, Avin
    AMERICAN HEALTH AND DRUG BENEFITS, 2014, 7 (09): : 479 - 486
  • [35] Riociguat for the treatment of pulmonary hypertension
    Meis, Tobias
    Behr, Juergen
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (16) : 2419 - 2427
  • [36] Riociguat For The Treatment Of Pulmonary Arterial Hypertension And Chronic Thromboembolic Pulmonary Hypertension: Real-Life Data From The Expert Registry
    Gall, H.
    Ghofrani, H. -A.
    Hoeper, M. M.
    Humbert, M.
    Gomez Sanchez, M. -A.
    Pittrow, D.
    Halank, M.
    Grunig, E.
    Wirtz, H.
    Klose, H.
    Ewert, R.
    Lange, T.
    Klotsche, J.
    Vachiery, J. -L.
    Nielsen-Kudsk, J. E.
    Snijder, R.
    Mascherbauer, R.
    Ulrich, S.
    Loffler-Ragg, J.
    Cottin, V.
    Tsangaris, I.
    Peacock, A.
    Meier, C.
    Brunn, M.
    Simonneau, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [37] Effectiveness and Safety of Riociguat as First-line or Combination Therapy in Pulmonary Arterial Hypertension (PAH): A Riociguat Users (ROAR) Registry Analysis
    White, R.
    Aranda, A. U.
    Chakinala, M. M.
    Mandras, S.
    Mcconnell, J. W.
    Miller, C. E.
    Sulica, R.
    Johnson, D.
    Carvajal, V.
    Bansilal, S.
    Kirkwold, J.
    Kim, N. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [38] Riociguat in the treatment of pulmonary hypertension
    Vaquero Valencia, M.
    REVISTA CLINICA ESPANOLA, 2014, 214 (03): : 162 - 163
  • [39] Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Benza, Raymond L.
    Ghofrani, Hossein-Ardeschir
    Grunig, Ekkehard
    Hoeper, M. Marius
    Jansa, Pavel
    Jing, Zhi-Cheng
    Kim, Nick H.
    Langleben, David
    Simonneau, Gerald
    Wang, Chen
    Busse, Dennis
    Meier, Christian
    Ghio, Stefano
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (10): : 1172 - 1180
  • [40] Riociguat Dose Titration in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) or Pulmonary Arterial Hypertension (PAH)
    Ghofrani, H. A.
    Hoeper, M. M.
    Hoeffken, G.
    Halank, M.
    Weimann, G.
    Grimminger, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345